Skip to main content

Advertisement

Table 2 Patient and tumour characteristics

From: Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy

Characteristic Number (%)
Age Median: 59
Range: [31, 82]
Sex Male: 136 (88.9%)
Female: 17 (11.1%)
Smoking status Non-smoker: 68 (44.4%)
< =10 Packs/year: 25 (16.3%)
> 10–20 Packs/year: 18 (11.8%)
> 20 Packs/year: 27 (17.6%)
Unknown: 15 (9.8%)
Primary site Tonsil: 92 (60.2%)
Base of tongue: 55 (35.9%)
Oropharynx: 1 (0.7%)
Other: 5 (3.2%)
T stage 7th Ed/8th Ed T1: 47 (30.7%)
T2: 67 (43.8%)
T3: 29 (19.0%)
T4a: 9 (5.9%)
T4b: 1 (0.7%)
N stage 7th Ed N0: 17 (11.1%)
N1: 27 (17.6%)
N2a: 16 (10.5%)
N2b: 60 (39.2%)
N2c: 28 (18.3%)
N3: 5 (3.3%)
N stage 8th Ed N0: 17 (11.1%)
N1: 103 (66.9%)
N2: 28 (18.3%)
N3: 5 (3.3%)
Systemic therapy Nil: 39 (25.4%)
Weekly Cisplatin: 85 (55.6%)
Cetuximab: 10 (6.5%)
Neoadjuvant TPF: 14 (9.2%)